These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9816630)

  • 1. Diagnosis of prostate carcinoma on biopsy specimens improved by basal-cell-specific anti-cytokeratin antibody (34 beta E12).
    Freibauer C
    Wien Klin Wochenschr; 1998 Sep; 110(17):608-11. PubMed ID: 9816630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH; Signoretti S; Loda M
    Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.
    Wojno KJ; Epstein JI
    Am J Surg Pathol; 1995 Mar; 19(3):251-60. PubMed ID: 7532918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign mimics of prostatic adenocarcinoma on needle biopsy.
    Gaudin PB; Reuter VE
    Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal adenocarcinoma in prostate needle biopsy tissue.
    Thorson P; Humphrey PA
    Am J Clin Pathol; 2000 Dec; 114(6):896-909. PubMed ID: 11338479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens.
    Jiang Z; Iczkowski KA; Woda BA; Tretiakova M; Yang XJ
    Am J Clin Pathol; 2004 Jan; 121(1):99-107. PubMed ID: 14750247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU; Haber MM; Chen X
    Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
    Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO
    Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histopathological features of prostate cancer].
    Kozuka Y; Imai H; Yamanaka M; Kozuka M; Uchida K; Shiraishi T
    Nihon Rinsho; 2005 Feb; 63(2):231-6. PubMed ID: 15714971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recutting prostate needle core biopsies with high grade prostatic intraepithelial neoplasia increases detection of adenocarcinoma.
    Rapp DE; Msezane LP; Reynolds WS; Lotan TL; Obara P; O'Connor RC; Taxy JB; Gerber GS; Zagaja GP
    Can J Urol; 2009 Feb; 16(1):4484-9. PubMed ID: 19222887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of prostate carcinoma in core needle biopsy--definition of minimal criteria for the diagnosis of cancer in biopsy material.
    Algaba F; Epstein JI; Aldape HC; Farrow GM; Lopez-Beltran A; Maksem J; Orozco RE; Pacelli A; Pisansky TM; Trias I
    Cancer; 1996 Jul; 78(2):376-81. PubMed ID: 8674022
    [No Abstract]   [Full Text] [Related]  

  • 17. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
    Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
    Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Premalignant and benign lesions in nodules of adenomatous hyperplasia].
    Miján Ortiz JL; Fernández Rodríguez A; Fernández Ruiz PL; de la Fuente Serrano A; Nogales Fernández F; Zuluaga Gómez A
    Arch Esp Urol; 1996 Sep; 49(7):684-7. PubMed ID: 9020004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma.
    Netto GJ; Epstein JI
    Am J Surg Pathol; 2006 Sep; 30(9):1184-8. PubMed ID: 16931964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.